Re: Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

Arthur I Sagalowsky

doi:10.1016/j.eururo.2010.07.014

Re: Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	630
Number of pages	1
Journal	European urology
Volume	58
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2010.07.014
State	Published - Oct 2010

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2010.07.014

Cite this

Re: Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology. / Sagalowsky, Arthur I.
In: European urology, Vol. 58, No. 4, 10.2010, p. 630.

Research output: Contribution to journal › Comment/debate › peer-review

@article{71747165854946c4b19fdc335aa673eb,

title = "Re: Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology",

author = "Sagalowsky, {Arthur I}",

year = "2010",

month = oct,

doi = "10.1016/j.eururo.2010.07.014",

language = "English (US)",

volume = "58",

pages = "630",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

AU - Sagalowsky, Arthur I

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=77956503415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956503415&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2010.07.014

DO - 10.1016/j.eururo.2010.07.014

M3 - Comment/debate

C2 - 20848746

AN - SCOPUS:77956503415

SN - 0302-2838

VL - 58

SP - 630

JO - European Urology

JF - European Urology

IS - 4

ER -

Re: Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this